In Silico Characterization of a Novel Bioactive Compound Derived from Psidium Guajava 4-[5-(Pyridin-4-Yl)-1,2,4-Oxadiazol-3-Yl]-1,2,5-Oxadiazol-3-Amine: A Potential Inhibitor for Targeting Signaling Proteins Involved in Diabetes Development. Int. J. Pharm. Sci. Drug Res. 2024, 16 (2), 180-190. https://doi.org/10.25004/IJPSDR.2024.160207.